This week: Triggering ferromagnetism in graphene, exceptional cancer cell growth inhibitors, stabilizing of sickle cell hemoglobin — and more! Each and every day, ACS grants free access to a new peer-reviewed research article from one of the Society’s journals. These articles are specially chosen by a team of scientific editors of ACS journals from around […]
This week: Triggering ferromagnetism in graphene, exceptional cancer cell growth inhibitors, stabilizing of sickle cell hemoglobin — and more!
Each and every day, ACS grants free access to a new peer-reviewed research article from one of the Society’s journals. These articles are specially chosen by a team of scientific editors of ACS journals from around the world to highlight the transformative power of chemistry. Access to these articles will remain open to all as a public service.
Check out this week’s picks!
***
Antineoplastic Agents. 603. Quinstatins: Exceptional Cancer Cell Growth Inhibitors
J. Nat. Prod., Article ASAP
DOI: 10.1021/acs.jnatprod.6b01006
***
Doping with Graphitic Nitrogen Triggers Ferromagnetism in Graphene
J. Am. Chem. Soc., Article ASAP
DOI: 10.1021/jacs.6b12934
***
Two-Dimensional Folding of Polypeptides into Molecular Nanostructures at Surfaces
ACS Nano, Article ASAP
DOI: 10.1021/acsnano.6b06145
***
Fragment-Based Approach for the Evaluation of NMR Chemical Shifts for Large Biomolecules Incorporating the Effects of the Solvent Environment
J. Chem. Theory Comput., Article ASAP
DOI: 10.1021/acs.jctc.6b00922
***
Chemical Proteomics Maps Brain Region Specific Activity of Endocannabinoid Hydrolases
ACS Chem. Biol., Article ASAP
DOI: 10.1021/acschembio.6b01052
***
Hard X-ray Photon-in Photon-out Spectroscopy as a Probe of the Temperature-Induced Delocalization of Electrons in Nanoscale Semiconductors
Chem. Mater., Article ASAP
DOI: 10.1021/acs.chemmater.6b05218
***
Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin
ACS Med. Chem. Lett., Article ASAP
DOI: 10.1021/acsmedchemlett.6b00491
***
Love ACS Editors’ Choice? Get a weekly e-mail of the latest ACS Editor’s Choice articles and never miss a breakthrough!
